$NLNK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LUMOS PHARMA, INC.. Get notifications about new insider transactions in LUMOS PHARMA, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2021 | NLNK | LUMOS PHARMA, INC. | Schuchart Aaron | Chief Business Offi ... | Option Exercise | A | 10.13 | 7,805 | 79,065 | 7,805 | |
| Jun 03 2021 | NLNK | LUMOS PHARMA, INC. | Schuchart Aaron | Chief Business Offi ... | Option Exercise | A | 10.13 | 7,805 | 79,065 | 7,805 | |
| May 24 2021 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Option Exercise | A | 10.36 | 2,910 | 30,148 | 2,910 | |
| May 24 2021 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Grant | A | 0.00 | 367 | 0 | 1,076 | 709 to 1.1 K (+51.76 %) |
| Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | POWERS BRADLEY J | General Counsel | Payment of Exercise | F | 12.25 | 342 | 4,190 | 5,082 | 5.4 K to 5.1 K (-6.31 %) |
| Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | McKew John C. | Chief Scientific Of ... | Payment of Exercise | F | 12.25 | 1,036 | 12,691 | 13,226 | 14.3 K to 13.2 K (-7.26 %) |
| Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | Lawley Lori D | Principal Accountin ... | Payment of Exercise | F | 12.25 | 274 | 3,357 | 5,437 | 5.7 K to 5.4 K (-4.80 %) |
| Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | Langren Carl W. | Chief Financial Off ... | Payment of Exercise | F | 12.25 | 683 | 8,367 | 11,494 | 12.2 K to 11.5 K (-5.61 %) |
| Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | Hawkins Richard J | Chief Executive Off ... | Payment of Exercise | F | 12.25 | 1,522 | 18,645 | 745,382 | 746.9 K to 745.4 K (-0.20 %) |
| Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 22.24 | 101,600 | 2,259,797 | 784,568 | 886.2 K to 784.6 K (-11.47 %) |
| Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 23.57 | 3,912 | 92,194 | 886,168 | 890.1 K to 886.2 K (-0.44 %) |
| Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 24.11 | 1,000 | 24,108 | 890,080 | 891.1 K to 890.1 K (-0.11 %) |
| Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 25.05 | 4,378 | 109,665 | 891,080 | 895.5 K to 891.1 K (-0.49 %) |
| Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 24.35 | 11,794 | 287,157 | 895,458 | 907.3 K to 895.5 K (-1.30 %) |
| Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 22.64 | 931 | 21,082 | 907,252 | 908.2 K to 907.3 K (-0.10 %) |
| Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 22.47 | 28,108 | 631,620 | 908,183 | 936.3 K to 908.2 K (-3.00 %) |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Zoth Lota S. | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Zoth Lota S. | Director | Grant | A | 0.00 | 709 | 0 | 1,820 | 1.1 K to 1.8 K (+63.82 %) |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Raffin Thomas A. | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Raffin Thomas A. | Director | Grant | A | 0.00 | 709 | 0 | 7,889 | 7.2 K to 7.9 K (+9.87 %) |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | McCracken Joseph S | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | McCracken Joseph S | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Cunningham Emmett | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Cunningham Emmett | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | JOHNSON CHAD ALLEN | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | JOHNSON CHAD ALLEN | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | POWERS BRADLEY J | General Counsel | Option Exercise | A | 7.87 | 25,000 | 196,750 | 25,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | POWERS BRADLEY J | General Counsel | Grant | A | 0.00 | 4,500 | 0 | 4,555 | 55 to 4.6 K (+8,181.82 %) |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | McKew John C. | Chief Scientific Of ... | Option Exercise | A | 7.87 | 65,000 | 511,550 | 65,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | McKew John C. | Chief Scientific Of ... | Grant | A | 0.00 | 13,000 | 0 | 13,000 | 0 to 13 K |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 7.87 | 25,000 | 196,750 | 25,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Lawley Lori D | Principal Accountin ... | Grant | A | 0.00 | 4,500 | 0 | 4,842 | 342 to 4.8 K (+1,315.79 %) |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 7.87 | 45,000 | 354,150 | 45,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Langren Carl W. | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 11,238 | 2.2 K to 11.2 K (+402.14 %) |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 7.87 | 45,000 | 354,150 | 45,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Kennedy Eugene P. | Chief Medical Offic ... | Grant | A | 0.00 | 9,000 | 0 | 10,484 | 1.5 K to 10.5 K (+606.47 %) |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Hawkins Richard J | Chief Executive Off ... | Option Exercise | A | 7.87 | 135,000 | 1,062,450 | 135,000 | |
| Apr 03 2020 | NLNK | LUMOS PHARMA, INC. | Hawkins Richard J | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 744,575 | 719.6 K to 744.6 K (+3.47 %) |
| Jan 06 2020 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Grant | A | 0.00 | 2,100 | 0 | 10,006 | 7.9 K to 10 K (+26.56 %) |
| Jan 06 2020 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Payment of Exercise | F | 2.21 | 376 | 831 | 13,721 | 14.1 K to 13.7 K (-2.67 %) |
| Jan 06 2020 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Payment of Exercise | F | 2.21 | 281 | 621 | 20,144 | 20.4 K to 20.1 K (-1.38 %) |
| Aug 27 2019 | NLNK | NEWLINK GENETICS C ... | POWERS BRADLEY J | Principal Executive ... | Payment of Exercise | F | 1.59 | 76 | 121 | 503 | 579 to 503 (-13.13 %) |
| Aug 06 2019 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 1.71 | 331,258 | 566,451 | 331,258 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | A | 1.77 | 13,424 | 23,760 | 13,424 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | A | 1.77 | 10,739 | 19,008 | 10,739 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | D | 7.07 | 48,324 | 341,651 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 4,437 | 7,853 | 4,437 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 17.42 | 13,309 | 231,843 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 2,391 | 4,232 | 2,391 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 10.78 | 4,782 | 51,550 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 8,887 | 15,730 | 8,887 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 10.78 | 17,774 | 191,604 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 1,588 | 2,811 | 1,588 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 44.60 | 6,349 | 283,165 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 5,220 | 9,239 | 5,220 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 21.23 | 15,659 | 332,441 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 4,000 | 7,080 | 4,000 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 14.71 | 12,000 | 176,520 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 3,968 | 7,023 | 3,968 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 13.30 | 11,902 | 158,297 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 1,190 | 2,106 | 1,190 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 10.02 | 2,380 | 23,848 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 5,952 | 10,535 | 5,952 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 10.02 | 11,904 | 119,278 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 11,905 | 21,072 | 11,905 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 3.07 | 23,809 | 73,094 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 11,905 | 21,072 | 11,905 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 3.07 | 23,809 | 73,094 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 2,445 | 4,328 | 2,445 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,582 | 8,110 | 4,582 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,582 | 8,110 | 4,582 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,587 | 8,119 | 4,587 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 6,875 | 12,169 | 6,875 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 6,875 | 12,169 | 6,875 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 15,889 | 28,124 | 15,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 9,167 | 16,226 | 9,167 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 7.85 | 110,000 | 863,500 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,297 | 7,606 | 4,297 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 6,641 | 11,755 | 6,641 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 7,813 | 13,829 | 7,813 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 8.90 | 37,500 | 333,750 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 73 | 129 | 73 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 177 | 313 | 177 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 250 | 443 | 250 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 7.73 | 1,000 | 7,730 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,826 | 8,542 | 4,826 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,550 | 8,054 | 4,550 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 15,625 | 27,656 | 15,625 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 10.55 | 50,000 | 527,500 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 695 | 1,230 | 695 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 24,306 | 43,022 | 24,306 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 10.78 | 50,000 | 539,000 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 66 | 117 | 66 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 241 | 427 | 241 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 330 | 584 | 330 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 2,525 | 4,469 | 2,525 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 34.73 | 12,641 | 439,022 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 313 | 554 | 313 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 2,188 | 3,873 | 2,188 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 46.73 | 10,000 | 467,300 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 174 | 308 | 174 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 2,326 | 4,117 | 2,326 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 39.05 | 10,000 | 390,500 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 469 | 830 | 469 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 7,032 | 12,447 | 7,032 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 30.48 | 30,000 | 914,400 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,724 | 8,361 | 4,724 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 11,944 | 21,141 | 11,944 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 22.85 | 50,000 | 1,142,500 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 16,667 | 29,501 | 16,667 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 15.33 | 50,000 | 766,500 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | A | 1.77 | 18,506 | 32,756 | 18,506 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | A | 1.77 | 13,218 | 23,396 | 13,218 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | D | 4.56 | 63,447 | 289,318 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 105 | 186 | 105 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 187 | 331 | 187 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 563 | 997 | 563 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 146 | 258 | 146 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 7.85 | 2,000 | 15,700 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 1,250 | 2,213 | 1,250 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 3,021 | 5,347 | 3,021 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 729 | 1,290 | 729 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 8.86 | 10,000 | 88,600 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 360 | 637 | 360 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 311 | 550 | 311 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 115 | 204 | 115 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 12.68 | 2,352 | 29,823 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 70 | 124 | 70 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 487 | 862 | 487 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 1,111 | 1,966 | 1,111 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 10.78 | 3,334 | 35,941 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 98 | 173 | 98 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 98 | 173 | 98 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 472 | 835 | 472 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 24.42 | 2,000 | 48,840 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 868 | 1,536 | 868 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 1,633 | 2,890 | 1,633 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 52.64 | 10,000 | 526,400 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 4,437 | 7,853 | 4,437 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 17.42 | 13,309 | 231,843 | 0 |